Investigating the effect of the 13-valent pneumococcal conjugate vaccine on major adverse cardiovascular events among Medicare enrollees aged ≥65 years in the United States First published 24/04/2025 Last updated 29/08/2025 EU PAS number:EUPAS1000000520 Study Ongoing